Dr. Agarwal's Health Care · NSE: AGARWALEYE · BSE: 544350
Q3 FY25 results · Oct–Dec 2024
Dr. Agarwal's Health Care reported revenue from operations of ₹430.72 crore and net profit of ₹28.24 crore for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 430.72 | — | — | — | — |
| Other income | 12.71 | — | — | — | — |
| Total income | 443.43 | — | — | — | — |
| Profit before tax | 40.99 | — | — | — | — |
| Net profit for the period | 28.24 | — | — | — | — |
| Attributable to shareholders of the company | 22.34 | — | — | — | — |
| EPS, basic (₹) | 0.73 | — | — | — | — |
| Net margin (%) | 6.6 | — | — |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 267.93 | — | — | — | — |
| Other income | 10.48 | — | — | — | — |
| Total income | 278.41 | — | — | — | — |
| Profit before tax | 12.10 | — | — | — | — |
| Net profit for the period | 7.62 | — | — | — | — |
| EPS, basic (₹) | 0.25 | — | — | — | — |
| Net margin (%) | 2.8 | — | — |
Consolidated
- Filed with BSE
- 15 Feb 2025, 16:52 IST
- Board meeting
- 14 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 15 Feb 2025, 16:52 IST
- Board meeting
- 14 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE